Intravitreal allogeneic mesenchymal stem cells: a non-randomized phase II clinical trial for acute non-arteritic optic neuropathy

Intravitreal allogeneic mesenchymal stem cells: a non-randomized phase II clinical trial for acute non-arteritic optic neuropathy

Abstract Background An effective treatment for acute non-arteritic ischemic optic neuropathy (NA-AION) has not been known or proven yet. Previous studies have suggested a neuroprotective effect of allogeneic bone marrow-derived mesenchymal stem cells. This study aims to report the results of a clini...

Full description

Bibliographic Details
Main Authors: Jose C. Pastor, Salvador Pastor-Idoate, Marina López-Paniagua, Marta Para, Francisco Blazquez, Esther Murgui, Verónica García, Rosa M. Coco-Martín
Format: Article
Language:English
Published: BMC 2023-09-01
Series:Stem Cell Research & Therapy
Subjects:
NA-AION
Acute anterior ischemic optic neuropathy
MSV®
Allogeneic bone marrow-derived mesenchymal stem cells
BM-MSCs
Bone marrow mesenchymal stem cells
Online Access:https://doi.org/10.1186/s13287-023-03500-7

Internet

https://doi.org/10.1186/s13287-023-03500-7

Similar Items